Advertisement
UK markets open in 2 hours 2 minutes
  • NIKKEI 225

    38,023.37
    +394.89 (+1.05%)
     
  • HANG SENG

    17,626.75
    +342.21 (+1.98%)
     
  • CRUDE OIL

    83.85
    +0.28 (+0.34%)
     
  • GOLD FUTURES

    2,347.50
    +5.00 (+0.21%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,371.57
    -82.62 (-0.16%)
     
  • CMC Crypto 200

    1,387.54
    +4.97 (+0.36%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Analyzing Boston Scientific’s Financial Performance

Analyzing Boston Scientific’s Financial Performance

In Q1 2018, Boston Scientific (BSX) generated sales of $2.4 billion compared to $2.2 billion in Q1 2017. The company’s cost of goods sold increased from $650 million in Q1 2017 to $672 million in Q1 2018. The increase was due to the positive impact of cost reductions from Boston Scientific’s process improvement programs and restructuring programs.